Predictions
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€224.55
30.10.20
30.10.20
-
31.10.20
31.10.20
1.09%
31.10.20
31.10.20
Some uniques
Risky Investment
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€224.55
30.10.20
30.10.20
-
31.10.20
31.10.20
1.09%
31.10.20
31.10.20
Some uniques
Risky Investment
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€224.55
30.10.20
30.10.20
-
31.10.20
31.10.20
1.09%
31.10.20
31.10.20
Some uniques
Risky Investment
SRP Groupe S.A.
Start price
Target price
Perf. (%)
€1.18
30.10.20
30.10.20
€3.20
04.11.21
04.11.21
73.43%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.36
30.10.20
30.10.20
€2.00
31.10.20
31.10.20
-25.00%
31.10.20
31.10.20
Risky Investment
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.45
29.10.20
29.10.20
-
04.11.21
04.11.21
-0.78%
04.11.20
04.11.20
Could be very worthwhile Investment >20% year
Charles Schwab Corp.
Start price
Target price
Perf. (%)
€34.40
29.10.20
29.10.20
-
04.11.21
04.11.21
26.48%
01.01.21
01.01.21
negative Cash Flow expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
BYD Co. Ltd
Start price
Target price
Perf. (%)
€17.02
29.10.20
29.10.20
€33.00
04.11.21
04.11.21
101.59%
05.11.21
05.11.21
Sustainability is important
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Apple Inc.
Start price
Target price
Perf. (%)
€96.02
29.10.20
29.10.20
€140.00
04.11.21
04.11.21
36.97%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Apple Inc.
Start price
Target price
Perf. (%)
€96.02
29.10.20
29.10.20
€140.00
04.11.21
04.11.21
36.97%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Apple Inc.
Start price
Target price
Perf. (%)
€96.02
29.10.20
29.10.20
€140.00
04.11.21
04.11.21
36.97%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Apple Inc.
Start price
Target price
Perf. (%)
€96.02
29.10.20
29.10.20
€140.00
04.11.21
04.11.21
36.97%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€236.70
29.10.20
29.10.20
€245.00
30.10.20
30.10.20
-5.13%
30.10.20
30.10.20
Some uniques
Risky Investment
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€236.70
29.10.20
29.10.20
€245.00
30.10.20
30.10.20
-5.13%
30.10.20
30.10.20
Some uniques
Risky Investment
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€236.70
29.10.20
29.10.20
€245.00
30.10.20
30.10.20
-5.13%
30.10.20
30.10.20
Some uniques
Risky Investment
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€371.00
29.10.20
29.10.20
-
04.11.21
04.11.21
8.65%
30.12.20
30.12.20
EBIT growth >5% per year expected
Very low/no dividend yield expected
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€371.00
29.10.20
29.10.20
-
04.11.21
04.11.21
8.65%
30.12.20
30.12.20
EBIT growth >5% per year expected
Very low/no dividend yield expected
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€371.00
29.10.20
29.10.20
-
04.11.21
04.11.21
8.65%
30.12.20
30.12.20
EBIT growth >5% per year expected
Very low/no dividend yield expected